Valeant Pharmaceuticals Completes Acquisition of Sanitas Group

August 19, 2011

MISSISSAUGA, Ontario, Aug. 19, 2011 /PRNewswire via COMTEX/ --

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that effective August 19, 2011, the company completed its previously announced acquisition of AB Sanitas (NASDAQ OMX: SAN1L).

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. More information about Valeant can be found at www.valeant.com.

Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com

(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)

Annual Report

2015 Annual Report

The right products
The right philosophy.
record organic growth.

View All